Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Paediatric antiretroviral therapy challenges with emerging integrase resistance

5 Jul 2024

Abstract excerpt

PURPOSE OF REVIEW: Universal antiretroviral (ART) coverage and virological suppression are fundamental to ending AIDS in children by 2030. Availability of new paediatric dolutegravir (DTG)-based ART formulations is a major breakthrough and will undoubtedly help achieve this goal, but treatment challenges still remain. RECENT FINDINGS: Paediatric formulations remain limited compared to those for adults, especially...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytomegalovirus and herpesvirus research
Share to HIV/AIDS drug development and treatment
Share to HIV/AIDS Research and Interventions

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38967797
DOI: 10.1097/coh.0000000000000876

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Paediatric antiretroviral therapy challenges with emerging integrase resistancePMID 38967797Read ↗

Development of antiretroviral resistance in children with HIV in low- and middle-income countries.Semantic proximity Read ↗

Lamivudine monotherapy in children and adolescents: The devil is in the detail.Semantic proximity Read ↗

Emergence of Resistance in HIV-1 Integrase with Dolutegravir Treatment in a Pediatric Population from the IMPAACT P1093 StudySemantic proximity Read ↗

High Rates of Drug Resistance Among Newly Diagnosed HIV-infected Children in the National Prevention of Mother-to-child Transmission Program in TogoSemantic proximity Read ↗

Low Levels of Clinically Significant Drug Resistance Mutations to Dolutegravir Among Children Living with HIV Failing on First-Line Antiretroviral Therapy in Uganda.Semantic proximity Read ↗

HIV-1-resistance-associated mutations after failure of first-line antiretroviral treatment among children in resource-poor regions: a systematic review.Semantic proximity Read ↗

Pharmaco-virological Outcomes and Genotypic Resistance Profiles Among Children and Adolescents Receiving a Dolutegravir-Based Regimen in TogoSemantic proximity Read ↗

HIV-1 integrase resistance in the context of antiretroviral therapy in paediatric patients ‒ Northeast Brazil.Semantic proximity Read ↗

HIV drug resistance in children and adolescents on NNRTI-based antiretroviral therapy and subsequent virologic response to dolutegravir-based regimens in Ghana.Semantic proximity Read ↗

Drug resistance in the HIV-1-infected paediatric population worldwide: a systematic review.Semantic proximity Read ↗

High Drug Resistance Levels Compromise the Control of HIV Infection in Pediatric and Adult Populations in Bata, Equatorial Guinea.Semantic proximity Read ↗

Virological outcomes and genotypic resistance on dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trialSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.